Search Results 7571-7580 of 34163 for oral

  1. C Dan Johnson, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerG.I. Radiology, American Board of Radiology. 2000 - 2003. MemberEquipment, Space and Personnel Committee, Department of Radiology. 2000 - 2001.

  2. Otolaryngology (ENT)/Head and Neck Surgery - Doctors - Mayo Clinic

    ... Oral surgery, Salivary gland surgery, Throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  5. Akash Sharma, M.D., M.B.A. - Doctors and Medical Staff - Mayo Clinic

    Board ExaminerOral Examination, American Board of Radiology. 2005 - 2007. MemberRadiation Safety Committee, Allegheny General Hospital. 2005 - present. Member ...

  6. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  8. Hemodialysis - Mayo Clinic

    Diabetes · High blood pressure (hypertension) · Kidney inflammation (glomerulonephritis) · Kidney cysts (polycystic kidney disease) · Inherited kidney diseases ...

  9. A Phase 2 Study Of ONC206 In Advanced Pheochromocytoma And Paraganglioma - Mayo Clinic

    Is ≥18 years of age. Is able to swallow oral tablets. Has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2, assessed within 7 days ...

  10. Phase 2/3 Study Of Efficacy And Safety Of THRV-1268 In Long QT Syndrome Type 2 (LQTS 2) - Mayo Clinic

    The purpose of this study is to evaluate the effect of oral THRV-1268 on QTcF interval by AUC method in participants with LQTS 2. Participation eligibility.